Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,212,568
  • Shares Outstanding, K 227,752
  • Annual Sales, $ 1,526 M
  • Annual Income, $ -41,460 K
  • 60-Month Beta 0.72
  • Price/Sales 6.09
  • Price/Cash Flow 15.36
  • Price/Book 3.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.29
  • Number of Estimates 4
  • High Estimate 0.29
  • Low Estimate 0.28
  • Prior Year 0.27
  • Growth Rate Est. (year over year) +7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.77 +16.34%
on 02/28/20
42.41 -4.62%
on 03/26/20
+3.98 (+10.91%)
since 02/27/20
3-Month
32.97 +22.71%
on 02/04/20
42.41 -4.62%
on 03/26/20
+6.78 (+20.14%)
since 12/27/19
52-Week
25.04 +61.54%
on 10/09/19
43.16 -6.28%
on 12/02/19
+0.42 (+1.05%)
since 03/27/19

Most Recent Stories

More News
Here's Why You Should Hold on to LabCorp (LH) Stock for Now

Investors continue to be optimistic about LabCorp (LH) on its strong segmental results in the fourth quarter of 2019.

MDT : 89.89 (-2.23%)
RMD : 141.95 (-3.12%)
QGEN : 40.45 (-0.88%)
LH : 128.71 (-6.09%)
QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy

QIAGEN (QGEN) releases test kits in the United States to speed up the diagnosis of coronavirus per the FDA's latest policy.

MDT : 89.89 (-2.23%)
RMD : 141.95 (-3.12%)
QGEN : 40.45 (-0.88%)
HRC : 99.53 (-2.61%)
ROSEN, A HIGHLY RANKED FIRM, Continues to Investigate Securities Claims Against QIAGEN N.V.

Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Qiagen N.V. (NYSE: QGEN) resulting from allegations that Qiagen may...

QGEN : 40.45 (-0.88%)
The Global Cell Surface Markers Market is expected to grow from USD 528.12 Million in 2018 to USD 941.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.60%

Reportlinker.com announces the release of the report "Global Cell Surface Markers Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025"...

QGEN : 40.45 (-0.88%)
SHAREHOLDER INVESTIGATION: Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - NTGN, FSB, FSCT, QGEN

Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional...

NTGN : 2.26 (-1.74%)
FSB : 20.68 (-5.18%)
FSCT : 31.22 (+0.03%)
QGEN : 40.45 (-0.88%)
Here's Why You Should Add Hill-Rom Stock to Your Portfolio

Investors continue to be optimistic about Hill-Rom (HRC) on its strong domestic and international results in the first quarter of fiscal 2020.

MDT : 89.89 (-2.23%)
RMD : 141.95 (-3.12%)
QGEN : 40.45 (-0.88%)
HRC : 99.53 (-2.61%)
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

QGEN : 40.45 (-0.88%)
DHR : 138.58 (-0.06%)
QDEL : 94.31 (+6.00%)
AYTU : 1.8200 (+13.75%)
CODX : 9.15 (-2.66%)
Lifshitz Law Firm, P.C. Announces Investigation of Neon Therapeutics, Inc., Qiagen N.V., Stein Mart, Inc., and Taubman Centers, Inc.

EQNX::TICKER_START (NASDAQ:NTGN),(NYSE:QGEN),(NASDAQ:SMRT),(NYSE:TCO), EQNX::TICKER_END

NTGN : 2.26 (-1.74%)
QGEN : 40.45 (-0.88%)
SMRT : 0.4880 (-6.15%)
TCO : 46.39 (-3.37%)
Coronavirus Test Kit Demand to Drive These 3 Stocks

Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

QGEN : 40.45 (-0.88%)
DHR : 138.58 (-0.06%)
QDEL : 94.31 (+6.00%)
AYTU : 1.8200 (+13.75%)
CODX : 9.15 (-2.66%)
Spok Appoints Christine Cournoyer to Board of Directors

Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced that, effective immediately, it has appointed Christine M. Cournoyer, who most recently served as the Chairperson...

QGEN : 40.45 (-0.88%)
CDNA : 21.85 (-6.54%)
SPOK : 10.47 (-2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade QGEN with:

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 41.12
1st Resistance Point 40.79
Last Price 40.45
1st Support Level 40.01
2nd Support Level 39.56

See More

52-Week High 43.16
Last Price 40.45
Fibonacci 61.8% 36.24
Fibonacci 50% 34.10
Fibonacci 38.2% 31.96
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar